Beam Therapeutics Inc.
BEAMCIK 0001745999 · last filing Jul 2, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
50,000 bought / 50,373 sold
net −373 sh · −$1.71M
- buys
- 3
- sells
- 5
- insiders active
- 2
Filing tape
Filed Thu, Jul 2, 2026
- −373 sh · $13.0K
Simon Amy — Chief Medical Officer
- Sold373Common Stock@ $34.73→ 102,363 held
Filed Wed, Jul 1, 2026
- −0 sh · $1.70M
Evans John M. — CEO · Director
- Exercised18,663Common Stock@ $0.67→ 1,065,868 held
- Exercised6,337Common Stock@ $1.03→ 1,072,205 held
- Sold13,421Common Stock@ $35.13→ 1,058,784 held
- Sold11,579Common Stock@ $35.91→ 1,047,205 held
- Exercised25,000Common Stock@ $1.03→ 1,072,205 held
- Sold23,100Common Stock@ $34.26→ 1,049,105 held
- Sold1,900Common Stock@ $34.84→ 1,047,205 held
- Exercised18,663Stock Option (Right to Buy)→ 9 held
- Exercised6,337Stock Option (Right to Buy)→ 230,804 held
- Exercised25,000Stock Option (Right to Buy)→ 205,804 held
Insiders on this tape
- Simon AmyChief Medical Officer
- Evans John M.CEO · Director
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.